Ohkuma H, Tsurutani H, Suzuki S
Department of Neurosurgery, Hirosaki University School of Medicine, Hirosaki, Japan.
Stroke. 2001 May;32(5):1176-80. doi: 10.1161/01.str.32.5.1176.
Rebleeding is a major cause of death and disability in aneurysmal subarachnoid hemorrhage (SAH); however, there has been no report focusing on rebleeding before hospitalization in neurosurgical or neurological institutions. The aim of this study was to clarify the incidence of prehospitalization rebleeding, its impact on the clinical course and prognosis in patients with aneurysmal SAH, and the possible factors inducing it.
In 273 patients who were admitted to our institution within 24 hours after the initial SAH bleeding and whose clinical course before admission could be fully evaluated, the patients' clinical conditions and CT findings on admission, operability, prognosis, and possible factors inducing rebleeding were comparatively evaluated between the patients with and without an episode of prehospitalization rebleeding.
Of the 273 patients, 37 (13.6%) patients suffered from 39 episodes of rebleeding in the ambulance or at the referring hospital before admission to our hospital. The peak time of rebleeding was within 2 hours (77%), in which the incidence was statistically significant compared with that occurring 2 to 8 hours after the initial SAH bleeding (P<0.01). The group experiencing rebleeding showed more severe Hunt and Hess grades on admission, higher rates of intracerebral hematoma, of intraventricular hematoma, and of subdural hematoma on CT scan on admission, less operability, and poorer prognoses with statistically significant differences compared with the group that did not experience rebleeding. Systolic arterial pressure >160 mm Hg was a possible risk factor of rebleeding (odds ratio 3.1, 95% CI 1.5 to 6.8).
Rebleeding during transfer and at the referring hospital is not rare. To improve overall outcome of aneurysmal SAH, the results obtained in this study should be made available to general practitioners and the doctors devoted to emergency medicine.
再出血是动脉瘤性蛛网膜下腔出血(SAH)患者死亡和致残的主要原因;然而,在神经外科或神经内科机构中,尚无关于住院前再出血的报道。本研究的目的是明确动脉瘤性SAH患者住院前再出血的发生率、其对临床病程和预后的影响以及可能诱发再出血的因素。
对273例在首次SAH出血后24小时内入院且入院前临床病程可全面评估的患者,比较有和无住院前再出血发作的患者在入院时的临床状况、CT表现、可手术性、预后以及可能诱发再出血的因素。
在这273例患者中,37例(13.6%)患者在入院前于救护车或转诊医院发生了39次再出血。再出血的高峰时间在2小时内(77%),与首次SAH出血后2至8小时发生再出血的情况相比,其发生率具有统计学意义(P<0.01)。与未发生再出血的组相比,发生再出血的组入院时Hunt和Hess分级更严重,入院时CT扫描显示脑内血肿、脑室内血肿和硬膜下血肿的发生率更高,可手术性更低,预后更差,差异具有统计学意义。收缩压>160 mmHg是再出血的一个可能危险因素(比值比3.1,95%可信区间1.5至6.8)。
转运过程中和转诊医院的再出血并不罕见。为改善动脉瘤性SAH的总体预后,应将本研究结果告知全科医生和从事急诊医学的医生。